Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

EU loses bid for speedier AstraZeneca vaccine deliveries

Stock MarketsJun 18, 2021 01:25PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Empty vials of Oxford/AstraZeneca's COVID-19 vaccine are seen at a vaccination centre in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman/File Photo

By Francesco Guarascio and Alistair Smout

BRUSSELS/LONDON (Reuters) -The European Union on Friday lost its bid to speed up deliveries of AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccines, the first of its legal challenges against the drugmaker that rocked the bloc as it scrambled to shore up supplies.

AstraZeneca said the EU had lost its legal case, but European Commission President Ursula von der Leyen said the court ruling supported its view that the Anglo-Swedish pharmaceutical giant had failed to honour its commitments.

The row plunged the EU into crisis earlier this year as states, under pressure to speed up vaccinations, scrambled for shots. Brussels has since largely cut ties with AstraZeneca, choosing not to buy any more of its vaccines for now.

The drugmaker had committed to do its best to deliver 300 million doses to the 27-nation bloc by the end of June, but production delays led it to revise this to 100 million vaccines.

This delayed the EU's vaccination drive as the bloc had initially bet on AstraZeneca to deliver the largest volume, sparking a bitter row and EU legal action to get at least 120 million doses by the end of June.

However, the judge ruled that AstraZeneca must deliver only 80.2 million doses by a deadline of Sept. 27. The drugmaker said it would "substantially exceed" that by the end of June.

The court said in a statement that AstraZeneca must deliver 15 million doses by July 26, another 20 million by Aug. 23 and a further 15 million by Sept. 27, to reach a total of 50 million doses, which are in addition to 30 million that had been given to the EU when the legal case began.

Should it miss the deadlines in the ruling, AstraZeneca would face a penalty of "10 euros ($11.8) per dose not delivered", the judge said, less than the 10 euros per dose per day fine the EU had sought in bringing its legal action.

AstraZeneca will remain bound to do its best to deliver 300 million doses to the EU, and a new hearing is to be held in September when compliance with the contract will be assessed again, the ruling said.

The EU had asked all 300 million doses to be delivered by the end of September, but the court did not set a deadline.

EU data shows the company has already shipped nearly 70 million doses, more than half of which were delivered after the start of the legal proceedings.

This brings AstraZeneca close to already meeting the court's requirement of 80 million doses in total by Sept. 27.

SERIOUS BREACH

An EU lawyer also said the judgment meant that as a proof of best effort, AstraZeneca will have to deliver COVID-19 vaccines from a factory in Britain, if needed to meet its EU commitments.

The company had said it could not immediately deliver to the EU doses from an Oxford BioMedica factory because it had to supply Britain first.

The ruling said that AstraZeneca may have committed a serious breach of the contract by reserving Oxford BioMedica's output for the British market. However a final decision on this will be made in a second legal case.

AstraZeneca said the court had found that the EU had no exclusivity or right of priority over other parties.

"The judgment also acknowledged that the difficulties experienced by AstraZeneca in this unprecedented situation had a substantial impact on the delay," it said in a statement.

"AstraZeneca now looks forward to renewed collaboration with the European Commission to help combat the pandemic in Europe."

The EU last month launched a second legal action against AstraZeneca over an alleged breach of the supply contract, which will continue after the summer. Friday's ruling was over whether AstraZeneca must speed up vaccine deliveries.

EU loses bid for speedier AstraZeneca vaccine deliveries
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
Leo Mu
Leo Mu Jun 18, 2021 8:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Forget about the vaccine, they produces it at no profit. Focus on the acquisition of Alexion, EU to decide on Astrazeneca's $39 billion Alexion deal by July 5. I expect AZN to $60+.
Gavin Mendes
Gavin Mendes Jun 18, 2021 9:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Corrupt EU try to make money during the pandemic ..
Millennial Dip Buyer
Millennial Dip Buyer Jun 18, 2021 9:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They're trying to vaccinate their people, similar to what the US did.  Interestingly, the US and its pharmaceutical companies took bids on vaccines and has also failed to deliver on time - prioritizing the US market.  The fines are to punish a company for failing to deliver on a promise - something you never see happen in the US, since integrity doesn't exist there.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email